Smith & Nephew Snats ADR (SNN)

$32.73 -0.23 (-0.70%)
Market Cap 13.77B
Revenue (ttm) 5.81B
Net Income (ttm) 412.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 16.11
Profit Margin 7.09%
Debt to Equity Ratio 0.60
Volume 293,100
Avg Vol 573,288
Day's Range N/A - N/A
Shares Out 424.35M
Stochastic %K 34%
Beta 0.63
Analysts Sell
Price Target $35.05

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization o...

Industry: Medical Devices
Sector: Healthcare
Phone: 44 1923 477 100
Address:
Building 5, Croxley Park Hatters Lane, Watford, United Kingdom
BillionerOfKing
BillionerOfKing Dec. 3 at 5:20 PM
$SNN Current Stock Price: $32.90 Contracts to trade: $35 SNN Dec 19 2025 Call Entry: $0.05 Exit: $0.07 ROI: 46% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 6:18 PM
Canaccord Genuity updates rating for Smith & Nephew ( $SNN ) to Hold, target set at 36 → 34.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 11:03 PM
$SNN Share Price: $36.49 Contract Selected: Mar 20, 2026 $35 Calls Buy Zone: $1.27 – $1.58 Target Zone: $2.08 – $2.54 Potential Upside: 54% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MahiMe
MahiMe Oct. 22 at 5:35 PM
$SNN https://www.globenewswire.com/en/search/exchange/nyse,nasdaq?pagesize=10#:~:text=UFC%C2%AE%20and%20Smith%2BNephew%20announce%20multi%2Dyear%20extension%20of%20partnership UFC® and Smith+Nephew announce multi-year extension of partnership
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 12:44 PM
Bernstein updates rating for Smith & Nephew ( $SNN ) to Market Perform, target set at 37.5.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 6 at 6:08 PM
$SNN Really good write-up that perfectly summarizes SNN's present situation. So if you want to bring your SNN knowledge up to date or just discover SNN, this is required reading. https://beyondspx.com/quote/SNN/analysis/smith-nephew-s-resurgent-growth-and-profitability-drive-nyse-snn
0 · Reply
30AMoney
30AMoney Sep. 5 at 6:05 PM
$SPY buy necessities such as health insurance $UNH & hip/knee replacements $SNN. just a thought...
0 · Reply
scottgrant2
scottgrant2 Sep. 4 at 2:11 AM
$SNN please buy $RCEL their products could really help ur business and patients
0 · Reply
BringDownThoseReps
BringDownThoseReps Aug. 31 at 12:07 PM
$MDAI $MDT $SNN $TMO $GEHC
0 · Reply
thebestincredit
thebestincredit Aug. 28 at 7:18 PM
$SNN my wife worked for this company for over 10 years and it’s a shit show now with new management. We were buying shares at discount for a few years and literally about to sell all right now at this price. GLTA
0 · Reply
Latest News on SNN
Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript

Nov 6, 2025, 7:16 AM EST - 4 weeks ago

Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript

Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release

Nov 5, 2025, 9:58 AM EST - 4 weeks ago

Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release

Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Oct 27, 2025, 11:30 AM EDT - 5 weeks ago

Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

UFC® and Smith+Nephew announce multi-year extension of partnership

Oct 22, 2025, 11:30 AM EDT - 6 weeks ago

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

Oct 3, 2025, 11:53 AM EDT - 2 months ago

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Oct 1, 2025, 1:00 PM EDT - 2 months ago

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

Sep 3, 2025, 10:16 AM EDT - 3 months ago

Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System

Smith & Nephew: Doing Better And Still Offers Value

Aug 7, 2025, 11:37 AM EDT - 4 months ago

Smith & Nephew: Doing Better And Still Offers Value

Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:06 AM EDT - 4 months ago

Smith & Nephew plc (SNN) Q2 2025 Earnings Call Transcript

Top 2 Health Care Stocks You May Want To Dump In Q3

Aug 5, 2025, 9:11 AM EDT - 4 months ago

Top 2 Health Care Stocks You May Want To Dump In Q3

STAA

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Jul 7, 2025, 10:00 AM EDT - 5 months ago

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures

Jun 24, 2025, 10:00 AM EDT - 5 months ago

Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Jun 23, 2025, 8:00 AM EDT - 5 months ago

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Jun 18, 2025, 4:00 AM EDT - 6 months ago

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Jun 9, 2025, 10:00 AM EDT - 6 months ago

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

May 27, 2025, 10:00 AM EDT - 6 months ago

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

May 7, 2025, 8:00 AM EDT - 7 months ago

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

May 5, 2025, 2:00 AM EDT - 7 months ago

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript

May 2, 2025, 5:42 PM EDT - 7 months ago

Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Apr 19, 2025, 10:09 PM EDT - 8 months ago

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

Apr 3, 2025, 9:34 AM EDT - 8 months ago

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

NVO

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Mar 11, 2025, 11:00 AM EDT - 9 months ago

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Mar 10, 2025, 11:00 AM EDT - 9 months ago

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Mar 6, 2025, 10:00 AM EST - 9 months ago

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

Mar 3, 2025, 8:20 AM EST - 9 months ago

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Feb 25, 2025, 11:00 AM EST - 10 months ago

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 10:16 AM EST - 10 months ago

Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript

UK's Smith+Nephew beats annual profit expectations

Feb 25, 2025, 2:09 AM EST - 10 months ago

UK's Smith+Nephew beats annual profit expectations

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Feb 16, 2025, 6:00 PM EST - 10 months ago

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

Feb 3, 2025, 10:00 AM EST - 10 months ago

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

Smith & Nephew Getting No Credit For Self-Improvement Efforts

Jan 29, 2025, 8:37 AM EST - 11 months ago

Smith & Nephew Getting No Credit For Self-Improvement Efforts

Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention

Jan 14, 2025, 8:00 AM EST - 11 months ago

Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention

Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin

Jan 14, 2025, 4:22 AM EST - 11 months ago

Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Dec 19, 2024, 10:00 AM EST - 1 year ago

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Dec 16, 2024, 10:00 AM EST - 1 year ago

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Big investors call for break-up of Smith & Nephew, FT reports

Nov 14, 2024, 12:24 AM EST - 1 year ago

Big investors call for break-up of Smith & Nephew, FT reports

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Nov 10, 2024, 1:02 PM EST - 1 year ago

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript

Nov 2, 2024, 8:57 AM EDT - 1 year ago

Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript

Smith & Nephew slashes annual revenue forecast on weak China

Oct 31, 2024, 3:17 AM EDT - 1 year ago

Smith & Nephew slashes annual revenue forecast on weak China

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Oct 16, 2024, 9:00 AM EDT - 1 year ago

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

This stock is 'boring' but has 'fantastic' risk-reward: Scharf

Sep 18, 2024, 12:40 PM EDT - 1 year ago

This stock is 'boring' but has 'fantastic' risk-reward: Scharf

First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Sep 18, 2024, 10:00 AM EDT - 1 year ago

First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Sep 10, 2024, 10:00 AM EDT - 1 year ago

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Smith & Nephew Delivering On Its Turnaround Promise

Aug 21, 2024, 8:30 PM EDT - 1 year ago

Smith & Nephew Delivering On Its Turnaround Promise

Smith & Nephew plc (SNN) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:21 PM EDT - 1 year ago

Smith & Nephew plc (SNN) Q2 2024 Earnings Call Transcript

Smith & Nephew shares rise as profit beats market forecast

Aug 1, 2024, 3:28 AM EDT - 1 year ago

Smith & Nephew shares rise as profit beats market forecast

Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins

Jul 13, 2024, 9:20 AM EDT - 1 year ago

Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins

Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge

Jul 5, 2024, 9:35 AM EDT - 1 year ago

Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge

BillionerOfKing
BillionerOfKing Dec. 3 at 5:20 PM
$SNN Current Stock Price: $32.90 Contracts to trade: $35 SNN Dec 19 2025 Call Entry: $0.05 Exit: $0.07 ROI: 46% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 6:18 PM
Canaccord Genuity updates rating for Smith & Nephew ( $SNN ) to Hold, target set at 36 → 34.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 11:03 PM
$SNN Share Price: $36.49 Contract Selected: Mar 20, 2026 $35 Calls Buy Zone: $1.27 – $1.58 Target Zone: $2.08 – $2.54 Potential Upside: 54% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MahiMe
MahiMe Oct. 22 at 5:35 PM
$SNN https://www.globenewswire.com/en/search/exchange/nyse,nasdaq?pagesize=10#:~:text=UFC%C2%AE%20and%20Smith%2BNephew%20announce%20multi%2Dyear%20extension%20of%20partnership UFC® and Smith+Nephew announce multi-year extension of partnership
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 12:44 PM
Bernstein updates rating for Smith & Nephew ( $SNN ) to Market Perform, target set at 37.5.
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 6 at 6:08 PM
$SNN Really good write-up that perfectly summarizes SNN's present situation. So if you want to bring your SNN knowledge up to date or just discover SNN, this is required reading. https://beyondspx.com/quote/SNN/analysis/smith-nephew-s-resurgent-growth-and-profitability-drive-nyse-snn
0 · Reply
30AMoney
30AMoney Sep. 5 at 6:05 PM
$SPY buy necessities such as health insurance $UNH & hip/knee replacements $SNN. just a thought...
0 · Reply
scottgrant2
scottgrant2 Sep. 4 at 2:11 AM
$SNN please buy $RCEL their products could really help ur business and patients
0 · Reply
BringDownThoseReps
BringDownThoseReps Aug. 31 at 12:07 PM
$MDAI $MDT $SNN $TMO $GEHC
0 · Reply
thebestincredit
thebestincredit Aug. 28 at 7:18 PM
$SNN my wife worked for this company for over 10 years and it’s a shit show now with new management. We were buying shares at discount for a few years and literally about to sell all right now at this price. GLTA
0 · Reply
JarvisFlow
JarvisFlow Aug. 18 at 12:30 PM
Canaccord Genuity has adjusted their stance on Smith & Nephew ( $SNN ), setting the rating to Hold with a target price of 28 → 36.
1 · Reply
30AMoney
30AMoney Aug. 5 at 3:30 PM
$SPY $SNN i'm taking some profits off the table!
1 · Reply
Inamar06
Inamar06 Aug. 5 at 1:56 PM
$SNN 500 million stock buy back. Who knew, this is a valid business and ppl still need their hip and knee implants, among other things.
0 · Reply
jdlman
jdlman Aug. 5 at 11:20 AM
$SNN looks good
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 15 at 12:25 PM
$ORGO $SNN $IART Organogenesis Holding (ORGO), Smith & Nephew (SNN) & Integra LifeSciences (IART) Also Fall on CMS Publication https://ooc.bz/l/70000
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 4:42 PM
$SNN just dropped a game-changer for orthopedic surgeons 🦴 They launched TRIGEN MAX — the only tibia nailing system with side-specific nails for more precise, low-impact fracture repair. Full details on this tech expansion here 👉 https://www.zacks.com/stock/news/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554882_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 2:21 PM
$SNN launches innovative TRIGEN MAX Tibia Nailing System — could this boost its market share? 🚀 📈 Year-to-date, shares up 21.6%, outpacing the industry’s 6.6% growth. 🔧 Unique side-specific nails aim to optimize fragment fixation and minimize soft tissue irritation, strengthening SNN's position in orthopedic trauma. Discover how this could impact SNN's future performance 👉 https://www.zacks.com/commentary/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-body-192&ADID=SYND_STOCKTWITS_TWEET_2_2554882_BODY_192
0 · Reply
scottgrant2
scottgrant2 Jun. 23 at 5:32 PM
$RCEL wish smith and nephew would go ahead and buy them.. $SNN
1 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 4:12 PM
$SNN partners with Standard Health for UK's first Orthopaedic ASC! 🏥 📈 SNN shares have gained 16.3% in the year-to-date period vs. the industry’s 3.7% 🚀 Positions SNN in the high-growth ASC market 🔧 Enhances surgical tech adoption + boosts recurring revenue See what this means for SNN's growth strategy 👉 https://www.zacks.com/commentary/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-body&ADID=SYND_STOCKTWITS_TWEET_2_2520779_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 2:43 PM
$SNN just made a strategic move that could shake up the orthopedic space 🦴 Teaming with Standard Health, it’s launching the UK’s first orthopedic ASC — a big play to boost surgical efficiency and fuel growth. See why this could be a game-changer for SNN 👉 https://www.zacks.com/stock/news/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2520779_TEASER
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 7:57 PM
Canaccord Genuity has adjusted their stance on Smith & Nephew ( $SNN ), setting the rating to Hold with a target price of 27 → 28.
0 · Reply